11 October 2024
| Oct 11th 2024 | HALL A | |
| 07:30 | 08:30 | Early Bird Expert Opinion Session-I: Surgical Planning & Technique Selection |
| Moderators: Giuseppe Catanuto, Nicola Rocco | ||
| Discussants: Geok Hoon Lim, Jamila Alazhri, Elisabeth Elder, Leena Chagla | ||
| 08:30 | 10:30 | Session I: Implant-Based Breast Reconstruction |
| Chairs: Selahattin Ozmen, Ugur Anil Bingol | ||
| 08:30 | 08:45 | Usage of dermal and capsular flaps in breast reconstruction |
| Akin Yucel | ||
| 08:45 | 09:00 | Replacing shaped breast implants with round: Are outcomes better or worse? |
| Erdem Guven | ||
| 09:00 | 09:15 | The reverse expansion: A new era for the breast expanders |
| Filip Stillaert | ||
| 09:15 | 09:30 | Why we do less implant based breast reconstruction in Finland |
| Sinikka Suominen | ||
| 09:30 | 09:45 | Change of algorithm in immediate implant based breast reconstruction |
| Jian Farhadi | ||
| 09:45 | 10:00 | Current situation in breast implant – associated malignancies and breast implant disease |
| Suhan Ayhan | ||
| 10:00 | 10:30 | Q&A / Discussion |
| 10:30 | 11:00 | SATELLITE SYMPOSIUM  Moderator: Mehmet Suhan Ayhan Polytech presentation (5 min.) Speaker: Karsten Hemmrich The new era of aesthetic breast reconstruction after mastectomy (25 min) Speaker: Barbara Cagli |
| 11:00 | 11:10 | Fully wrap implants with ADM: Why? Michail Sorotos |
| 11:10 | 11:30 | COFFEE BREAK |
| 11:30 | 13:00 | Session II: Lymphedema & Management |
| Chairs: Cenk Demirdover, Anil Demiroz | ||
| 11:30 | 11:45 | New concepts in lymphedema |
| Alphonse Taghian | ||
| 11:45 | 12:00 | Lymphedema prevention and management strategies in breast reconstruction |
| Gemma Pons | ||
| 12:00 | 12:15 | The future of lymphedema surgery |
| Jaume Masia | ||
| DEBATE: Direct-to-Implant Reconstruction (DTI) & Postmastectomy Radiotherapy (PMRT) | ||
| 12:15 | 12:30 | DTI followed by PMRT is the preferred option |
| Philip Poortmans | ||
| 12:30 | 12:45 | DTI followed by PMRT is NOT the preferred option |
| Burcu Celet Ozden | ||
| 12:45 | 13:00 | Human breast capsules from 5 different implant surfaces: Expectations vs reality |
| Barbara Cagli | ||
| 13:00 | 14:00 | LUNCH |
| 14:00 | 16:00 | Session III: Autologous Breast Reconstruction |
| Chairs: Serhan Tuncer, Bulent Sacak | ||
| 14:00 | 14:15 | Our experience in breast reconstruction and lymphedema with “Symani” robotic surgery |
| Gemma Pons | ||
| 14:15 | 14:30 | Partial breast reconstruction using local tissue rearrangement |
| Sinikka Suominen | ||
| 14:30 | 14:45 | How to avoid empty upper pole in autologous reconstruction |
| Christoph Andree | ||
| 14:45 | 15:00 | Single- stage autologous breast reconstruction without monitor island |
| Jian Farhadi | ||
| 15:00 | 15:15 | The lumbar flap in breast reconstruction |
| Filip Stillaert | ||
| 15:15 | 15:30 | Salvage breast reconstruction failure: Strategies after total and major partial flap necrosis |
| Christoph Andree | ||
| 15:30 | 16:00 | Key points to get a good aesthetic outcome after autologous breast reconstruction |
| Jaume Masia | ||
| 16:00 | 16:30 | SATELLITE SYMPOSIUM  Moderator: Guldeniz Karadeniz Cakmak De-escalation of radiation for low-risk breast cancer using intra-operative ablation – Is it feasible? Speakers: Suzanne Klimberg (online), Cem Yilmaz |
| 16:30 | 17:00 | COFFEE BREAK |
| 17:00 | 18:45 | Session IV: High Risk & Prevention Chairs: Taner Korkmaz, Varol Celik |
| 17:00 | 17:15 | Approach to non-BRCA high-moderate risk genes |
| Banu Arun | ||
| 17:15 | 17:30 | Building on hereditary gene panels: Polygenic risk score |
| Ahmet Yesilyurt | ||
| 17:30 | 17:45 | Contralateral breast irradiation in BRCA carries: The enigma for physicians? |
| Philip Poortmans | ||
| 17:45 | 18:00 | Q&A / Discussion |
| 18:00 | 18:45 | PANEL: Patients with pathogenic gene mutations |
| Moderators: Basak Oyan Uluc, Cem Yilmaz | ||
| Discussants: Banu Arun, Ahmet Yesilyurt, Evrim Tezcanli, Shawna Willey, Gul Esen, Mehmet Bayramicli | ||
| Oct 11th 2024 | HALL B | |
| 08:30 | 10:30 | Session I: Adjuvant Systemic Treatment in Early Disease-I Chairs: Nil Molinas Mandel, Erdem Goker |
| 08:30 | 08:50 | How to define high risk in hormone-positive breast cancer (BC) and how to treat? |
| Michael Gnant | ||
| 08:50 | 09:10 | Optimal use of targeted therapy approaches in triple negative early stage breast cancer |
| Hope Rugo | ||
| 09:10 | 09:30 | De-escalation of systemic treatment in early stage HER2+ BC: What is next? |
| Karima Oualla | ||
| 09:30 | 09:50 | What is the role of genomic tests for radiation oncologists? |
| Maja Maraldo | ||
| 09:50 | 10:10 | Integrations of radiation therapy with targeted treatments for breast cancer (BC): The consensus |
| Icro Meattini | ||
| 10:10 | 10:30 | Q&A / Discussion |
| 10:30 | 11:00 | SATELLITE SYMPOSIUM  The past and present of TNBC treatment Speaker: Yesim Eralp |
| 11:00 | 11:30 | COFFEE BREAK |
| 11:30 | 13:00 | Session II: Adjuvant Systemic Treatment in Early Disease-II Chairs: Handan Onur Topuzlu, Yasemin Kemal |
| DEBATE: Genomic tests | ||
| 11:30 | 11:45 | There is a role for genomic tests in HR+, HER2-, N+ BC in premenopausal women |
| Sema Sezgin Goksu | ||
| 11:45 | 12:00 | There is NO role for genomic tests in HR+, HER2-, N+ BC in premenopausal women |
| Sana Al Sukhun | ||
| 12:00 | 12:15 | Q&A / Discussion |
| 12:15 | 13:00 | PANEL: Systemic treatment at adjuvant setting |
| Moderators: Yesim Eralp, Mahmut Muslumanoglu Narrator: Orcun Can |
||
| Discussants: Sitki Tuzlali, Icro Meattini, Arzu Oguz, Abdulaziz Al-Saif, Norran Hussein | ||
| 13:00 | 14:00 | LUNCH |
| 14:00 | 16:00 | Session III: Neoadjuvant Systemic Treatment Chairs: Idris Yucel, Sernaz Uzunoglu |
| 14:00 | 14:15 | Role of imaging in the prediction and determination of response |
| Eva Fallenberg | ||
| 14:15 | 14:30 | How to predict response to immunotherapy? |
| Marleen Kok | ||
| 14:30 | 14:45 | Neoadjuvant endocrine treatment |
| Karima Oualla | ||
| 14:45 | 15:00 | Q&A / Discussion |
| 15:00 | 16:00 | PANEL: Multidisciplinary breast cancer management at neoadjuvant setting |
| Moderators: Ozlem Sonmez, Atakan Sezer Narrator: Elif Senocak Tasci |
||
| Discussants: Didem Colpan Oksuz, Fatma Tokat, Hope Rugo, DG Vijay, Eva Fallenberg, Michalis Kontos, Ashutosh Kothari | ||
| 16:00 | 16:30 | SATELLITE SYMPOSIUM  Moderator: Varol Celik Multidisciplinary approach to Prosigna: How can intrinsic molecular subtypes guide therapeutic decisions for breast cancer patients? Speakers: Ozge Gumusay, Abeer Shaban |
| 16:30 | 17:00 | COFFEE BREAK |
| 17:00 | 18:45 | SELECTED PAPERS Chairs: Mehmet Velidedeoglu, Okan Avcı, Osman Köstek Discussants: Sebnem Orguc, Sahin Lacin, Sinem Eroglu |
| 17:00 | 17:15 | OP-023/ A machine learning–derived clinical decision rule for the assessment of axillary lymph node status in breast cancer: The influence of primary tumor burden and US shear-wave elastography Kaan Celik |
| 17:15 | 17:30 | OP-024/ Node marking techniques and targeted axillary dissection in cN1 patients undergoing neoadjuvant chemotherapy: Analysis of initial 546 participants in ATNEC trial (NCT04109079) Abeer M Shaaban |
| 17:30 | 17:45 | OP-026/ Implant reconstruction: Findings from the Australian Breast Device Registry Melanie Walker |
| 17:45 | 18:00 | OP-025/ Combined analysis of the NEOSENTITURK-trials MF18-02 and MF18-03 cohorts of clinically node-positive patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy Neslihan Cabioglu |
| 18:00 | 18:15 | OP-027/ Tumor microenvironment modulation by tumor-associated macrophages: Implications for neoadjuvant chemotherapy response in breast cancer Gizem Oner |
| 18:15 | 18:30 | OP-028/ Elacestrant in various combinations in patients with estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer: Preliminary data from ELEVATE, a phase 1b/2, open-label, umbrella study Hope Rugo |
| 18:30 | 18:45 | OP-029/ EILEEN Study: A retrospective real-world analysis of response rates with ribociclib and endocrine therapy in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer Muhammet Ali Kaplan |
| Oct 11th 2024 | HALL C | |
| 08:30 | 10:30 | Session I: Genetic Risk Management in Breast Cancer (BC) Chairs: Inci Gultekin, Serap Yucel |
| 08:30 | 08:50 | Genetic risk: 5W1H (Whom? what? when? where? and how?) |
| Umut Altunoglu | ||
| 08:50 | 09:10 | Promoting healthy lifestyles in women at genetic mutation |
| Celia Diez de los Rios | ||
| 09:10 | 09:30 | Fertility management in the patient with a genetic mutation |
| Merve Tuncer | ||
| 09:30 | 09:50 | Patients’ perspectives on genetic testing, expectations and coping methods |
| Yasemin Uslu | ||
| 09:50 | 10:10 | Family-to-child communication in hereditary BC |
| Celia Diez de los Rios | ||
| 10:10 | 10:30 | Q&A / Discussion |
| 10:30 | 11:00 | SATELLITE SYMPOSIUM  Why and when to ask or not for Oncotype DX Speakers: Basak Oyan Uluc, Christos J. Markopoulos |
| 11:00 | 11:30 | COFFEE BREAK |
| 11:30 | 13:00 | Session II: Metastatic Breast Cancer (BC) Nursing. A Challenging Grey Area Chairs: Seref Komurcu, Derya Subasi Sezgin |
| 11:30 | 11:50 | Balancing the goals of care and treatment in the changing landscape of metastatic BC |
| Maria Noblet | ||
| 11:50 | 12:05 | Current challenges of metastatic BC |
| Claire Ryan | ||
| 12:05 | 12:20 | Courageous conversations with the patient and family |
| Claire Ryan | ||
| 12:20 | 12:35 | Global research trends in palliative care for BC |
| Gulbeyaz Can | ||
| 12:35 | 12:55 | Ethical, legal, and financial considerations in metastatic BC |
| Gurkan Sert | ||
| 12:55 | 13:00 | Q&A / Discussion |
| 13:00 | 14:00 | LUNCH |
| 14:00 | 16:00 | Session III: Young Women-Living With Breast Cancer (BC) In The Active Phase Of Life Chairs: Yasemin Uslu, Perihan Guner |
| 14:00 | 14:20 | Young patient living with BC |
| Celia Diez de los Rios | ||
| 14:20 | 14:40 | Young women with BC: Treatment, care and nursing implications |
| Maria Noblet | ||
| 14:40 | 15:00 | Oncofertility counseling & fertility preservation strategy: Good clinical practices |
| Tevfik Yoldemir | ||
| 15:00 | 15:20 | Couples adjustment to BC |
| Seda Er | ||
| 15:20 | 15:40 | Family models and cultural challenges in BC |
| Claire Ryan | ||
| 15:40 | 15:55 | Mothering whilst living with BC |
| Tugba Pehlivan Saribudak | ||
| 15:55 | 16:00 | Q&A / Discussion |
| 16:30 | 17:00 | COFFEE BREAK |
| 17:00 | 18:45 | Session IV: Psycho-Oncological Perspectives of a Highly Neglected Topic  PANEL: Mental health of caregivers of cancer patients and crucial role of healthcare professionals in addressing it |
| Moderators: Tania Estape, Ozan Bahcivan | ||
| Discussants: Berna Sabrioglu, Ozan Bahcivan, Fiorita Poulakaki, Aslihan Kaya | ||
| Oct 11th 2024 | HALL D | |
| 08:30 | 10:30 | Oral Papers |
| Chairs: Onur Dulgeroglu, Ashutosh Mishra, Maher Hassan | ||
| 08:30 | 08:45 | OP-001 / Initial outcomes of a novel technique minimal scar mastectomy Nathalie Liew |
| 08:45 | 09:00 | OP-002 / Combined endoscopy-assisted muscle-sparing Latissimus Dorsi flap harvesting with lipofilling enhancement as a new volume replacement technique in breast reconstruction Yaseer Sayed Ahmed |
| 09:00 | 09:10 | OP-003 / Evaluating the efficacy and outcomes of Latissimus Dorsi flap reconstruction in breast cancer management: A 13-year audit Rajinder Saggu |
| 09:15 | 09:30 | OP-004 / In the era of chest wall perforator flaps: Complications encountered after 100 procedures performed Mahmoud A. Alhussini |
| 09:30 | 09:45 | OP-005 / Surgical and aesthetic outcomes of chest wall perforator transposition flaps in partial breast reconstruction Amit Kumar |
| 09:45 | 10:00 | OP-006 / Immediate lipofilling as a novel technique for volume replacement in oncoplastic breast conservative surgery Yaseer Sayed Ahmed |
| 10:00 | 10:15 | OP-007 / Can oncoplastic breast-conserving surgery be the gold standard method in breast cancer treatment? A comparative analysis Mehmet Olcum |
| 10:15 | 10:30 | OP-008 / Tumescent-assisted dissection in breast surgery: Retrospective cohort analysis Salman Al Shaibani |
| 11:00 | 11:30 | COFFEE BREAK |
| 11:30 | 13:00 | Oral Papers |
| Chairs: Gunay Gurleyik, Aykut Soyder | ||
| 11:30 | 11:45 | OP-009 / Immediate breast reconstruction after nipple-sparing mastectomy with prepectoral implant placement supported by a partial coverage technique employing late absorbable synthetic mesh Merve Tokocin |
| 11:45 | 12:00 | OP-010 / Whole breast reconstruction from a real-world cancer surgeon’s perspective: Revisiting the pedicled TRAM flap Esha Pai |
| 12:00 | 12:15 | OP-011 / Bipedicle deep inferior epigastric artery perforator flap for whole breast reconstruction: An institutional review Vineet Kumar |
| 12:15 | 12:30 | OP-012 / Direct-to-implant retropectoral dual plane approach with autologous inferior-based dermal flap: Does SPY-elite laser angiographic system reduce complication rates? Hasan Buyukdogan |
| 12:30 | 12:45 | OP-013 / Application of a single-use negative pressure wound therapy system and comparison with the use of standard dressings after tissue expander replacement surgery with breast implants: Assessment of surgical site complications and scar quality Maja Molska |
| 12:45 | 13:00 | OP-014 / Evaluation of biocompatibility of polycaprolactone-based materials in implant-based breast reconstructions: A rat model study Hamit Koç |
| 13:00 | 14:00 | LUNCH |
| 14:00 | 16:00 | Oral Papers |
| Chairs: Urvashi Jain, Serap Yucel, Parvane Rustamova | ||
| 14:00 | 14:17 | OP-015 / Long term results of breast cancer patients with BRCA1/2 mutations treated with radiotherapy Huseyin Mert Buyuktarakci |
| 14:17 | 14:34 | OP-016 / Axillary radiotherapy following metastatic sentinel lymph node biopsy for T1-2 breast cancer patients: Real-world data Berrak Ege Korkut |
| 14:34 | 14:51 | OP-017 / RADIOSO Milan trial: Clinical and organizational benefits of SCOUT Radar-Localization-System for non-palpable lesions Andrea Polizzi |
| 14:51 | 15:08 | OP-018 / Comparison of the effectiveness of the Magtrace®-magnetic marker with the fluorescence visualization technique in the detection of sentinel lymph nodes in breast cancer: Optimization of surgical treatment Maja Molska |
| 15:08 | 15:25 | OP-019 / Single center experience of the HOLOGIC LOCalizer System for localizing impalpable breast Lesions Wafaa Ghazali |
| 15:25 | 15:42 | OP-021 / Efficacy of clip placement to the metastatic lymph node before neoadjuvant chemotherapy in breast cancer: Do we still believe the profitability? Yeliz Emine Ersoy |
| 15:42 | 15:59 | OP-022/ RDI index as a novel predictor of non-sentinel node positivity in ACOSOG Z0011 eligible breast cancer patients: Development of a prediction model Shafeek Shamsudeen |
| 16:30 | 17:00 | COFFEE BREAK |
| 17:00 | 19:00 |  SPONSORED SYMPOSIA & WORKSHOP: Navigation for Targeted Axillary SurgeryCo-Chairs: Thörsten Kühn, Guldeniz Karadeniz Cakmak |
| 17:00 | 17:15 | Deescalating of axillary surgery in node-positive breast cancer after neoadjuvant chemotherapy: Methods and outcomes |
| Neslihan Cabioglu | ||
| 17:15 | 17:30 | MALLORCA – Trial: Surgical MArker LocaLisation OR Clip and wire Application for targeted axillary dissection in node positive breast cancer patients |
| Constanze Elfgen | ||
| 17:30 | 17:45 | Experience with Sirius Pintuition for targeted axillary dissection |
| Cornelia Leo | ||
| 17:45 | 18:00 | CEM response staging and pre-operative imaging in breast and axilla surgery: An accessible alternative to breast MRI |
| Erkin Aribal | ||
| 18:00 | 19:00 |   Hands-on Practice: TAD/Axilla surgery with Pintiution & ICG on synthetic models |
| Guldeniz Karadeniz Cakmak, Neslihan Cabioglu, Cornelio Leo, Thorsten Kühn, Leena Chagla | ||
About Breastanbul 2024
BREASTANBUL, a beacon of scientific excellence, was initiated in 2014 with a singular focus on breast cancer. Our mission has been to converge diverse disciplines, fostering an environment where cutting-edge research thrives and innovative patient care takes center stage.
Organizing Secretariat
Please contact organizing secretariat for your registration & accommodation requests.
Professional Congress Organizer (PCO)
D Event Tourism Organization
İçerenköy Mah. Çayır Cad. No:5 Bay Plaza Kat:12
Ataşehir, İstanbul
Phone: +90 216 573 18 36
Web: www.devent.com.tr
e-mail: istanbul1@devent.com.tr